Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipation

New therapy with unique bacterial strain B. bifidum HI-MIMBb75 promises help for approximately 80 million Europeans suffering from irritable bowel syndrome1 - World's largest clinical OTC irritable bowel syndrome trial investigating the efficacy of this particular strain published in the renowned medical journal The Lancet Gastroenterology & Hepatology2 - Results show significant efficacy for all predominant irritable bowel syndrome symptoms and all subtypes while simultaneously improving patients’ quality of life2 (Gräfelfing/Munich, Germany) The world's largest OTC irritable bowel syndrome (IBS) trial comes up with remarkable results, which were recently published in the renowned medical journal The Lancet Gastroenterology & Hepatology. For the first time, leading German scientists around Prof. Dr. Peter Layer (Israelitic Hospital Hamburg) were able to prove the significant efficacy of a heat-inactivated bacterial strain on patients with IBS. Trial results show that B. bifidum HI-M

10 Inflammatory Bowel Disease (IBD) Nursing Care Plans - Nurseslabs

Irritable Bowel Syndrome

Frontiers Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis

The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of the Irritable Bowel Syndrome: A Randomized Trial: Annals of Internal Medicine: Vol 145, No 8

Irritable bowel syndrome - Wikipedia

The COVID-19 Pandemic and Post-Infection Irritable Bowel Syndrome: What Lies Ahead for Gastroenterologists - Clinical Gastroenterology and Hepatology

PDF) Herbal Therapy is Effective for Rifaximin Non-Responders with Small Intestinal Bacterial Overgrowth (SIBO) and the Irritable Bowel Syndrome (IBS)

Pharmacology of the New Treatments for Lower Gastrointestinal Motility Disorders and Irritable Bowel Syndrome - Camilleri - 2012 - Clinical Pharmacology & Therapeutics - Wiley Online Library

Cilansetron - New Treatment for IBS - Clinical Trials Arena

Irritable bowel syndrome: constipation-predominant (C-IBS)